{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:03:28Z","timestamp":1788498208733,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["532\/15"],"award-info":[{"award-number":["532\/15"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bpc.2021.106720","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T03:21:16Z","timestamp":1637119276000},"page":"106720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Advancements and future directions in research of the roles of insulin in amyloid diseases"],"prefix":"10.1016","volume":"281","author":[{"given":"Yifat","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2021.106720_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10534-005-3685-y","article-title":"Zinc-ligand interactions modulate assembly and stability of the insulin hexamer \u2014 a review","volume":"18","author":"Dunn","year":"2005","journal-title":"Biometals"},{"key":"10.1016\/j.bpc.2021.106720_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pharmthera.2012.07.006","article-title":"Insulin in the brain: there and back again","volume":"136","author":"Banks","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bpc.2021.106720_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnana.2015.00040","article-title":"Whole-brain mapping of the direct inputs and axonal projections of POMC and AgRP neurons","volume":"9","author":"Wang","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.bpc.2021.106720_bb0020","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1210\/jc.2009-1677","article-title":"Insulin modulates food-related activity in the central nervous system","volume":"95","author":"Guthoff","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bpc.2021.106720_bb0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nn.2847","article-title":"High-fat feeding promotes obesity via insulin receptor\/PI3K-dependent inhibition of SF-1 VMH neurons","volume":"14","author":"Klockener","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bpc.2021.106720_bb0030","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.cmet.2011.03.021","article-title":"Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis","volume":"13","author":"Konner","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.bpc.2021.106720_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/med.21440","article-title":"Bridging type 2 diabetes and Alzheimer\u2019s disease: assembling the puzzle pieces in the quest for the molecules with therapeutic and preventive potential","volume":"38","author":"de Matos","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bpc.2021.106720_bb0040","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1212\/WNL.0b013e3181ffe4f6","article-title":"Insulin metabolism and the risk of Alzheimer disease: the Rotterdam study","volume":"75","author":"Schrijvers","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bpc.2021.106720_bb0045","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2021.106720_bb0050","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/aje\/154.7.635","article-title":"Diabetes mellitus and risk of Alzheimer\u2019s disease and dementia with stroke in a multiethnic cohort","volume":"154","author":"Luchsinger","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.bpc.2021.106720_bb0055","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","article-title":"In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"Oskarsson","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bpc.2021.106720_bb0060","article-title":"Association between amylin and amyloid-beta peptides in plasma in the context of apolipoprotein E4 allele","volume":"9","author":"Qiu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bpc.2021.106720_bb0065","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1073\/pnas.0509386103","article-title":"Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer\u2019s disease","volume":"103","author":"Guo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2021.106720_bb0070","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1110\/ps.04707004","article-title":"Observation of sequence specificity in the seeding of protein amyloid fibrils","volume":"13","author":"Krebs","year":"2004","journal-title":"Protein Sci."},{"key":"10.1016\/j.bpc.2021.106720_bb0075","doi-asserted-by":"crossref","first-page":"17490","DOI":"10.1074\/jbc.M311300200","article-title":"Seeding specificity in amyloid growth induced by heterologous fibrils","volume":"279","author":"O\u2019Nuallain","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2021.106720_bb0080","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1039\/C5CP03338A","article-title":"Amylin-Abeta oligomers at atomic resolution using molecular dynamics simulations: a link between type 2 diabetes and Alzheimer\u2019s disease","volume":"18","author":"Baram","year":"2016","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.bpc.2021.106720_bb0085","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1021\/acschemneuro.5b00192","article-title":"Cross-seeding interaction between beta-amyloid and human islet amyloid polypeptide","volume":"6","author":"Hu","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bpc.2021.106720_bb0090","doi-asserted-by":"crossref","first-page":"10649","DOI":"10.1021\/acs.jpcb.6b07731","article-title":"Molecular mechanisms of the bindings between non-amyloid beta component oligomers and amylin oligomers","volume":"120","author":"Atsmon-Raz","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bpc.2021.106720_bb0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0014-5793(95)01512-4","article-title":"Effects of beta cell granule components on human islet amyloid polypeptide fibril formation","volume":"379","author":"Westermark","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bpc.2021.106720_bb0100","doi-asserted-by":"crossref","first-page":"21063","DOI":"10.1073\/pnas.1109773109","article-title":"Imaging dynamic insulin release using a fluorescent zinc indicator for monitoring induced exocytotic release (ZIMIR)","volume":"108","author":"Li","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2021.106720_bb0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1054-3589(05)52002-7","article-title":"Tissue expression and secretion of amylin","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.bpc.2021.106720_bb0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1042\/bj3430053","volume":"343","author":"Bai","year":"1999","journal-title":"Biochem J"},{"key":"10.1016\/j.bpc.2021.106720_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00125-003-1263-9","article-title":"Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study","volume":"47","author":"Gastaldelli","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.bpc.2021.106720_bb0120","doi-asserted-by":"crossref","first-page":"6476","DOI":"10.1002\/anie.200602034","article-title":"Molecular mapping of the recognition interface between the islet amyloid polypeptide and insulin","volume":"45","author":"Gilead","year":"2006","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bpc.2021.106720_bb0125","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jmb.2003.10.045","article-title":"The mechanism of insulin action on islet amyloid polypeptide fiber formation","volume":"335","author":"Larson","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bpc.2021.106720_bb0130","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1021\/ja504031d","article-title":"Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions","volume":"136","author":"Susa","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bpc.2021.106720_bb0135","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1111\/j.1742-4658.2009.07061.x","article-title":"Insulin is a kinetic but not a thermodynamic inhibitor of amylin aggregation","volume":"276","author":"Cui","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.bpc.2021.106720_bb0140","doi-asserted-by":"crossref","first-page":"33076","DOI":"10.1038\/srep33076","article-title":"Conformational ensemble of hIAPP dimer: insight into the molecular mechanism by which a green tea extract inhibits hIAPP aggregation","volume":"6","author":"Mo","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bpc.2021.106720_bb0145","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1021\/bm501326y","article-title":"Orientations of residues along the beta-arch of self-assembled amylin fibril-like structures lead to polymorphism","volume":"16","author":"Wineman-Fisher","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bpc.2021.106720_bb0150","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1039\/C8SC00481A","article-title":"Mechanistic perspective and functional activity of insulin in amylin aggregation","volume":"9","author":"Baram","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.bpc.2021.106720_bb0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1096\/fj.01-0442hyp","article-title":"A possible role for pi-stacking in the self-assembly of amyloid fibrils","volume":"16","author":"Gazit","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bpc.2021.106720_bb0160","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1002\/anie.201604833","article-title":"The strong influence of structure polymorphism on the conductivity of peptide fibrils","volume":"55","author":"Ivnitski","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bpc.2021.106720_bb0165","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1039\/c3cc42879f","article-title":"Effects of mutations in de novo designed synthetic amphiphilic beta-sheet peptides on self-assembly of fibrils","volume":"49","author":"Raz","year":"2013","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.bpc.2021.106720_bb0170","doi-asserted-by":"crossref","first-page":"4884","DOI":"10.1021\/acs.biochem.7b00344","article-title":"Identification of key interactions in the initial self-assembly of amylin in a membrane environment","volume":"56","author":"Christensen","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bpc.2021.106720_bb0175","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pneurobio.2009.07.008","article-title":"Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan","volume":"89","author":"Aleman","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bpc.2021.106720_bb0180","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1471-4159.2006.04368.x","article-title":"Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein","volume":"101","author":"Grunblatt","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bpc.2021.106720_bb0185","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3233\/JAD-2002-4504","article-title":"Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor","volume":"4","author":"Ling","year":"2002","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bpc.2021.106720_bb0190","doi-asserted-by":"crossref","first-page":"RC221","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002","article-title":"Alzheimer\u2019s beta-amyloid peptides compete for insulin binding to the insulin receptor","volume":"22","author":"Xie","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bpc.2021.106720_bb0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/acschemneuro.5b00325","article-title":"Reciprocal molecular interactions between the Abeta peptide linked to Alzheimer\u2019s disease and insulin linked to diabetes mellitus type II","volume":"7","author":"Luo","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bpc.2021.106720_bb0200","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1021\/acs.biochem.9b00696","article-title":"Insulin inhibits Abeta42 aggregation and prevents Abeta42-induced membrane disruption","volume":"58","author":"Long","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.bpc.2021.106720_bb0205","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1021\/acschemneuro.9b00645","article-title":"Inhibitory activity of insulin on Abeta aggregation is restricted due to binding selectivity and specificity to polymorphic Abeta states","volume":"11","author":"Baram","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bpc.2021.106720_bb0210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0968-0004(01)01876-X","article-title":"Insulin-degrading enzyme: embarking on amyloid destruction","volume":"26","author":"Kurochkin","year":"2001","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bpc.2021.106720_bb0215","doi-asserted-by":"crossref","first-page":"17342","DOI":"10.1073\/pnas.0506723102","article-title":"3D structure of Alzheimer\u2019s amyloid-beta(1-42) fibrils","volume":"102","author":"Luhrs","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2021.106720_bb0220","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1021\/bi051952q","article-title":"Experimental constraints on quaternary structure in Alzheimer\u2019s beta-amyloid fibrils","volume":"45","author":"Petkova","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.bpc.2021.106720_bb0225","doi-asserted-by":"crossref","first-page":"E4976","DOI":"10.1073\/pnas.1600749113","article-title":"Atomic-resolution structure of a disease-relevant Abeta(1-42) amyloid fibril","volume":"113","author":"Walti","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2021.106720_bb0230","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.2337\/diabetes.54.12.3343","article-title":"Peripheral hyperinsulinemia promotes tau phosphorylation in vivo","volume":"54","author":"Freude","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bpc.2021.106720_bb0235","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.pnpbp.2006.04.007","article-title":"Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer\u2019s disease, frontotemporal dementia and schizophrenia with therapeutic implications","volume":"30","author":"Deutsch","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bpc.2021.106720_bb0240","doi-asserted-by":"crossref","first-page":"19547","DOI":"10.1074\/jbc.272.31.19547","article-title":"Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons","volume":"272","author":"Hong","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bpc.2021.106720_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fncel.2019.00017","article-title":"The link between tau and insulin Signaling: implications for Alzheimer\u2019s disease and other Tauopathies","volume":"13","author":"Goncalves","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bpc.2021.106720_bb0250","doi-asserted-by":"crossref","first-page":"104739","DOI":"10.1016\/j.nbd.2020.104739","article-title":"Insulin deficiency promotes formation of toxic amyloid-beta42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer\u2019s disease model","volume":"137","author":"Imamura","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bpc.2021.106720_bb0255","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1471-4159.2000.0741587.x","article-title":"Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta","volume":"74","author":"Reynolds","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bpc.2021.106720_bb0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1471-4159.2004.02155.x","article-title":"Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau\u2019s ability to bind and stabilize microtubules","volume":"88","author":"Cho","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bpc.2021.106720_bb0265","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bbrc.2004.05.075","article-title":"The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer\u2019s disease-like tau phosphorylation","volume":"319","author":"Jamsa","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bpc.2021.106720_bb0270","first-page":"280","article-title":"Tau phosphorylation: physiological and pathological consequences","volume":"2005","author":"Stoothoff","year":"1739","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bpc.2021.106720_bb0275","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bpc.2021.106720_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030740","article-title":"Insulin resistance promotes Parkinson\u2019s disease through aberrant expression of alpha-synuclein, mitochondrial dysfunction, and deregulation of the polo-like kinase 2 signaling","volume":"9","author":"Hong","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.bpc.2021.106720_bb0285","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","article-title":"Insulin resistance and Parkinson\u2019s disease: a new target for disease modification?","volume":"145-146","author":"Athauda","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bpc.2021.106720_bb0290","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.2337\/dc10-1333","article-title":"Diabetes and the risk of developing Parkinson\u2019s disease in Denmark","volume":"34","author":"Schernhammer","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpc.2021.106720_bb0295","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/dc11-1511","article-title":"Risk of Parkinson disease onset in patients with diabetes: a 9-year population-based cohort study with age and sex stratifications","volume":"35","author":"Sun","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpc.2021.106720_bb0300","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2337\/dc06-2011","article-title":"Type 2 diabetes and the risk of Parkinson\u2019s disease","volume":"30","author":"Hu","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpc.2021.106720_bb0305","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/00207459309003322","article-title":"The relationship between diabetes mellitus and Parkinson\u2019s disease","volume":"69","author":"Sandyk","year":"1993","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.bpc.2021.106720_bb0310","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/01.WNL.0000138432.16676.4B","article-title":"Diabetes mellitus and progression of rigidity and gait disturbance in older persons","volume":"63","author":"Arvanitakis","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.bpc.2021.106720_bb0315","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2337\/dc08-0688","article-title":"Prospective cohort study of type 2 diabetes and the risk of Parkinson\u2019s disease","volume":"31","author":"Driver","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.bpc.2021.106720_bb0320","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1039\/C9TB01871A","article-title":"Fundamentals of cross-seeding of amyloid proteins: an introduction","volume":"7","author":"Ren","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bpc.2021.106720_bb0325","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1021\/acschemneuro.5b00204","article-title":"Non-amyloid-beta component of human alpha-synuclein oligomers induces formation of new abeta oligomers: insight into the mechanisms that link Parkinson\u2019s and Alzheimer\u2019s diseases","volume":"7","author":"Atsmon-Raz","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bpc.2021.106720_bb0330","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.1c00445","article-title":"Insights into the mechanistic perspective effect of insulin on the nonamyloidogenic component (NAC) and alpha-synuclein aggregation","author":"Abramov-Harpaz","year":"2021","journal-title":"ACS Chem. Neurosci."}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462221002039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462221002039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:57:00Z","timestamp":1759564620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462221002039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":66,"alternative-id":["S0301462221002039"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2021.106720","relation":{},"ISSN":["0301-4622"],"issn-type":[{"value":"0301-4622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancements and future directions in research of the roles of insulin in amyloid diseases","name":"articletitle","label":"Article Title"},{"value":"Biophysical Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpc.2021.106720","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106720"}}